Modalities
Facilitate the production of a wide range of biologic modalities with our state-of-the-art facilities and expert capabilities.
How can our modalities meet your needs?
Our development and manufacturing expertise spans a wide range of biologic modalities, including:
- Monoclonal antibodies (mAbs)
- Therapeutic recombinant proteins
- Recombinant enzymes
- Conjugated therapeutic proteins
- Bispecific proteins
- Fusion proteins
- Synthetic peptides
- Plasmid DNA (pDNA)
- Phytopharmaceuticals
In addition to our broad range of modalities, we can also support you throughout your product development lifecycle with services such as comprehensive analytical testing.
Why partner with Enzene?
We are a global CDMO and biosimilar developer dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
We understand that each modality has unique requirements, and we are committed to providing you with the highest quality products and services. Our flexible development and manufacturing platforms allow us to quickly and efficiently produce modalities, regardless of their complexity or scale.
Our proprietary continuous bioprocess manufacturing platform, EnzeneX™ further enhances production, with accelerated rates and a significant reduction in the cost of producing complex modalities — from mAbs to complex proteins.
Discover EnzeneX™
A platform that pushes your project further.
Unlocking higher yields across a range of biologics at significantly lower costs to you, our patented continuous bioprocess manufacturing platform represents the pinnacle of our ongoing commitment to innovation.
EnzeneX™ harnesses the power of intensified perfusion using alternate tangential flow (ATF) and automated multi-column chromatography to achieve continuous production of biologics.
Designed for efficiency and cost-effectiveness, EnzeneX™ enables uninterrupted loading and processing of materials, delivering superior product quality and manufacturing outcomes.
Meet the modalities experts
Himanshu Gadgil, PhD
Chief Executive Officer
Himanshu Gadgil, PhD
Chief Executive Officer
Dr. Himanshu Gadgil brings with him 24 years of experience in the pharmaceutical industry. He is the Chief Executive Officer at Enzene Biosciences Ltd. presiding over all business functions of the company. Under his leadership, Enzene has grown from a start-up biotech to a multi-vertical, multi-site product development and manufacturing service-based biopharmaceutical company.
Previously, as Sr. Vice President at Intas Pharmaceutical Ltd., he revitalized the commercial product pipeline, launching several biosimilar products globally. During his stint in the US, he led different facets of process and product development at Amgen, spearheading IND, BLA and Market authorizations of various blockbuster biotech products. At the inception of his career, he joined Waters Corporation where he pioneered development of QBD enabling multi-attribute methodologies for biopharmaceutical characterization.
Dr. Gadgil holds a PhD in Biochemistry from University of Tennessee and is a passionate scientific leader and innovator with over 50 publications and patents.
Abhishek Mathur, PhD, MBA
SVP, Head of Research and Development
Abhishek Mathur, PhD, MBA
SVP, Head of Research and Development
Dr. Abhishek Mathur is a seasoned healthcare executive with over 17 years of expertise in Biologics R&D, Product Development, and Operations. With a proven track record of interdisciplinary leadership across various functions spanning early research to product commercialization, his extensive experience reinforces our commitment to innovation and patient-centricity. Prior to joining Enzene, he held prominent roles at pioneering biopharmaceutical firms like Amgen and Regeneron in the US, where he successfully guided numerous products from early development to commercialization.
Dr. Mathur holds a Chemical Engineering degree from IIT Bombay, a PhD in Biological Sciences from Northwestern University (USA) and an MBA from Duke University (USA).
At Enzene, Abhishek heads Research and Development operations, guiding the team in innovative strategies and ensuring the smooth execution of projects to achieve the company's goals in biotechnology advancements.
Ravishankar Kasturi
VP, Head of Manufacturing Operations
Ravishankar Kasturi
VP, Head of Manufacturing Operations
Ravishankar Kasturi is the head of manufacturing operations at Enzene Biosciences. His extensive experience includes assignments at Reliance Life Sciences, as head of manufacturing and process development, followed by Dr. Reddy’s Biologics, and Uni-Sankyo ltd.
Ravi is a biochemical engineer by training with a bachelors in pharmacy. He has also completed executive management from the Indian Institute of Management Bangalore (IIMB), India.
Ravi leads all aspects of manufacturing processes of biologics/biosimilars, forming a diversified portfolio of products which include proteins derived from microbial fermentation and mammalian cell culture.
Related case studies
Join the revolution
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.